Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
주식 순위 #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
주가
$0.00695
마지막 동기화: 2024-10-29
시가총액
$536.40
변동 (1일)
-0.71%
변동 (1년)
0.00%
국가
US
거래 BIOLASE, Inc. (BIOL)

카테고리

BIOLASE, Inc. (BIOL)의 영업이익률
August 2026 기준 영업이익률 TTM: -36.48%
BIOLASE, Inc.의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 -36.48%입니다. 2022년 말 기준 영업이익률은 -52.28%였습니다.
BIOLASE, Inc.의 영업이익률 기록 (2000 ~ 2026)
매년 말 영업이익률
연도 영업이익률 변화
2026 (TTM) -36.48% 0.00%
2023 -36.48% -30.22%
2022 -52.28% 27.14%
2021 -41.12% -49.47%
2020 -81.37% 96.88%
2019 -41.33% -8.66%
2018 -45.25% 17.72%
2017 -38.44% 33.10%
2016 -28.88% -29.70%
2015 -41.08% 9.11%
2014 -37.65% 93.18%
2013 -19.49% 341.95%
2012 -4.41% -46.22%
2011 -8.20% -81.29%
2010 -43.83% 541.73%
2009 -6.83% -49.74%
2008 -13.59% 1.34%
2007 -13.41% 93.23%
2006 -6.94% -74.67%
2005 -27.40% 77.58%
2004 -15.43% -201.78%
2003 15.16% 78.35%
2002 8.50% -518.72%
2001 -2.03% -94.60%
2000 -37.62% 0.00%
유사 기업 또는 경쟁사의 영업이익률
회사 영업이익률 영업이익률 차이 국가
17.03% -100.47%
US
22.03% -100.60%
US
17.86% -100.49%
IE
21.46% -100.59%
US
28.09% -100.77%
US
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.